Association of Functional Changes in the Brain and the Perception of Pain in Patients With Chronic Inflammatory Bowel Diseases (IBD)
Primary Purpose
Inflammatory Bowel Disease
Status
Completed
Phase
Phase 2
Locations
Germany
Study Type
Interventional
Intervention
Transcranial direct current stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Inflammatory Bowel Disease
Eligibility Criteria
Inclusion Criteria:
- Inflammatory bowel disease
- Chronic pain (more than 3 months)
- Pain (VAS > 3/10)
Exclusion Criteria:
- Contraindication to transcranial direct current stimulation
- Contraindications to magnetic resonance imaging (MRI)
- Pregnancy
- Sever internal or psychiatric condition
Sites / Locations
- Charite University Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
Active tDCS
Sham tDCS
Arm Description
Active transcranial direct current stimulation
Sham transcranial direct current stimulation
Outcomes
Primary Outcome Measures
Functional and/or structural changes in the brain measured with cerebral MRI
Participants will be followed for 2 weeks
Changes in perception of pain measured with visual analogue scale and pain pressure threshold
Participants will be followed for 2 weeks
Secondary Outcome Measures
Changes in quality of life
Changes in functional symptoms (questionnaire: Irritable bowel syndrome - severity scoring system (IBS-SSS))
Questionnaire: irritable bowel syndrome - severity scoring system (IBS-SSS)
Changes in activity indices (Harvey-Bradshaw Index (HBI) or simple clinical colitis activity index)
(Harvey-Bradshaw Index (HBI) or simple clinical colitis activity index)
Changes in pain catastophizing scale
Changes in inflammation bBlood)
Changes in inflammation (stool - calprotectin)
Full Information
NCT ID
NCT02433470
First Posted
April 25, 2015
Last Updated
January 23, 2018
Sponsor
Charite University, Berlin, Germany
1. Study Identification
Unique Protocol Identification Number
NCT02433470
Brief Title
Association of Functional Changes in the Brain and the Perception of Pain in Patients With Chronic Inflammatory Bowel Diseases (IBD)
Study Type
Interventional
2. Study Status
Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
April 2015 (undefined)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charite University, Berlin, Germany
4. Oversight
5. Study Description
Brief Summary
In the study the investigators aim to test whether transcranial direct current stimulation (tDCS)-induced pain reduction is in association with functional changes in the brain measured with magnetic resonance imaging (MRI) in patients with chronic inflammatory bowel diseases (IBD).
Hypothesis: Transcranial direct current stimulation can reduce the perception of pain in patients with chronic inflammatory bowel diseases, which is in association with changes in the brain measured via MRI.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammatory Bowel Disease
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Active tDCS
Arm Type
Active Comparator
Arm Description
Active transcranial direct current stimulation
Arm Title
Sham tDCS
Arm Type
Sham Comparator
Arm Description
Sham transcranial direct current stimulation
Intervention Type
Device
Intervention Name(s)
Transcranial direct current stimulation
Other Intervention Name(s)
tDCS
Intervention Description
Transcranial direct current stimulation over the motor cortex
Primary Outcome Measure Information:
Title
Functional and/or structural changes in the brain measured with cerebral MRI
Description
Participants will be followed for 2 weeks
Time Frame
1 week
Title
Changes in perception of pain measured with visual analogue scale and pain pressure threshold
Description
Participants will be followed for 2 weeks
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Changes in quality of life
Time Frame
2 weeks
Title
Changes in functional symptoms (questionnaire: Irritable bowel syndrome - severity scoring system (IBS-SSS))
Description
Questionnaire: irritable bowel syndrome - severity scoring system (IBS-SSS)
Time Frame
2 weeks
Title
Changes in activity indices (Harvey-Bradshaw Index (HBI) or simple clinical colitis activity index)
Description
(Harvey-Bradshaw Index (HBI) or simple clinical colitis activity index)
Time Frame
2 weeks
Title
Changes in pain catastophizing scale
Time Frame
2 weeks
Title
Changes in inflammation bBlood)
Time Frame
2 weeks
Title
Changes in inflammation (stool - calprotectin)
Time Frame
2 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Inflammatory bowel disease
Chronic pain (more than 3 months)
Pain (VAS > 3/10)
Exclusion Criteria:
Contraindication to transcranial direct current stimulation
Contraindications to magnetic resonance imaging (MRI)
Pregnancy
Sever internal or psychiatric condition
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Magdalena S Prüß-Volz, MD
Organizational Affiliation
Charite University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Charite University Medicine
City
Berlin
ZIP/Postal Code
12200
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
Association of Functional Changes in the Brain and the Perception of Pain in Patients With Chronic Inflammatory Bowel Diseases (IBD)
We'll reach out to this number within 24 hrs